Prior infection of pigs with a recent humanH3N2 influenza virus confers minimal cross‐protection against aEuropean swineH3N2 virus
Open Access
- 29 March 2013
- journal article
- research article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 7 (6) , 1260-1268
Abstract
Background: H3N2 influenza viruses circulating in humans andEuropean pigs originate from the pandemicA/HongKong/68 virus. Because of slower antigenic drift in swine, the antigenic divergence between swine and human viruses has been increasing. It remains unknown to what extent this results in a reduced cross‐protection between recent human and swineH3N2 influenza viruses.Objectives: We examined whether prior infection of pigs with an old [A/Victoria/3/75 (A/Vic/75)] or a more recent [A/Wisconsin/67/05 (A/Wis/05)] humanH3N2 virus protected against aEuropean swineH3N2 virus [sw/Gent/172/08 (sw/Gent/08)]. Genetic and antigenic relationships between sw/Gent/08 and a selection of humanH3N2 viruses were also assessed.Results: After challenge with sw/Gent/08, all challenge controls had high virus titers in the entire respiratory tract at 3 days post‐challenge and nasal virus excretion for 5–6 days. Prior infection with sw/Gent/08 orA/Vic/75 offered complete virological protection against challenge. Pigs previously inoculated withA/Wis/05 showed similar virus titers in the respiratory tract as challenge controls, but the mean duration of nasal shedding was 1·3 days shorter. Unlike sw/Gent/08‐ andA/Vic/75‐inoculated pigs,A/Wis/05‐inoculated pigs lacked cross‐reactive neutralizing antibodies against sw/Gent/08 before challenge, but they showed a more rapid antibody response to sw/Gent/08 than challenge controls after challenge. Cross‐protection and serological responses correlated with genetic and antigenic differences.Conclusions: Infection immunity to a recent humanH3N2 virus confers minimal cross‐protection against aEuropean swineH3N2 virus. We discuss our findings with regard to the recent zoonotic infections of humans in the United States with a swine‐originH3N2 variant virus.Keywords
Funding Information
- Belgian Federal Public Service Health
- Food Chain Safety, and Environment (RT 09/6227)
- European Commission (FP7-GA 258084)
This publication has 36 references indexed in Scilit:
- Cross-reactive and Vaccine-Induced Antibody to an Emerging Swine-Origin Variant of Influenza A Virus Subtype H3N2 (H3N2v)The Journal of Infectious Diseases, 2012
- Comparison of Temporal and Spatial Dynamics of Seasonal H3N2, Pandemic H1N1 and Highly Pathogenic Avian Influenza H5N1 Virus Infections in FerretsPLOS ONE, 2012
- Lipoteichoic acid from Staphylococcus aureus exacerbates respiratory disease in porcine respiratory coronavirus-infected pigsThe Veterinary Journal, 2011
- MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony MethodsMolecular Biology and Evolution, 2011
- Glycosylation Focuses Sequence Variation in the Influenza A Virus H1 Hemagglutinin Globular DomainPLOS Pathogens, 2010
- Genetic Evolution of Swine Influenza A (H3N2) Viruses in China from 1970 to 2006Journal of Clinical Microbiology, 2008
- Swine Influenza (H3N2) Infection in a Child and Possible Community Transmission, CanadaEmerging Infectious Diseases, 2007
- Antigenic and Genetic Evolution of Swine Influenza A (H3N2) Viruses in EuropeJournal of Virology, 2007
- Cases of Swine Influenza in Humans: A Review of the LiteratureClinical Infectious Diseases, 2007
- Triple Reassortant H3N2 Influenza A Viruses, Canada, 2005Emerging Infectious Diseases, 2006